Metformin prevents metabolic side effects during systemic glucocorticoid treatment

A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients

(2016) Yusook Jeong et al.   Cancer Research and Treatment

Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment

(2015) Mio Akiyama et al.   CLINICAL RHEUMATOLOGY

Metformin: From Mechanisms of Action to Therapies

(2014) Marc Foretz et al.   Cell Metabolism

Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes

(2014) Alex Rafacho et al.   JOURNAL OF ENDOCRINOLOGY

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

(2014) Anila K. Madiraju et al.   NATURE

Metformin—mode of action and clinical implications for diabetes and cancer

(2014) Ida Pernicova et al.   Nature Reviews Endocrinology

Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial

(2013) Daniël H. van Raalte et al.   DIABETOLOGIA

Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses

(2013) D. I. Rendle et al.   EQUINE VETERINARY JOURNAL

Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial

(2013) Renate E van Genugten et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

(2013) Russell A. Miller et al.   NATURE

Glucose tolerance, insulin sensitivity and  -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

(2011) J. N. Hoes et al.   ANNALS OF THE RHEUMATIC DISEASES

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

(2011) D. H. van Raalte et al.   DIABETES CARE

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

(2010) A. Maida et al.   DIABETOLOGIA

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

(2010) Daniël H van Raalte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

AMPK Regulates Metabolic Actions of Glucocorticoids by Phosphorylating the Glucocorticoid Receptor through p38 MAPK

(2010) Nancy Nader et al.   MOLECULAR ENDOCRINOLOGY

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

(2009) Ling He et al.   CELL

Glucocorticoid-Induced Hyperglycemia

(2009) John Clore et al.   Endocrine Practice

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

(2009) D. H. van Raalte et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Translating the A1C Assay Into Estimated Average Glucose Values

(2008) D. M. Nathan et al.   DIABETES CARE

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome

(2008) Mirjam Christ-Crain et al.   FASEB JOURNAL

Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

(2008) Blerina Kola et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM